Evaluation of the Efficacy of Ponatinib in Ph+ ALL in the Real-world
NCT07356960
·
clinicaltrials.gov ↗
NOT_YET_RECRUITING
Status
103
Enrollment
OTHER
Sponsor class
Conditions
Acute Lymphobkastic Leukemia
Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
Sponsor
Gruppo Italiano Malattie EMatologiche dell'Adulto